Sign in

CIK 0000310158

  • Large accelerated filer

Merck & Co., Inc.

Sign in to watch
Ticker
MRK
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
EIN
221918501
Phone
+1 908-740-4000
Business address
126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
Former names
Merck & Co. Inc., SCHERING PLOUGH CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$8,611,875
in 1 filing

Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. DeLuca Richard R. −$8.6M EVP&Pres, Merck Animal Heallth sold 34% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-10-05 Davis Robert M EVP, Global Svcs & CFO Exercise or conversion +251,273 422,328.76
2020-10-05 Davis Robert M EVP, Global Svcs & CFO Sale −251,273 $81.03 $20.4M 171,055.76
2020-10-05 Davis Robert M EVP, Global Svcs & CFO Exercise or conversion · Stock Option (Right to Buy) −251,273 0
2020-09-30 Seidman Christine E Director Grant or award · Phantom Stock +195.9 $82.95 $16K 3,054.24
2020-09-30 WENDELL PETER C Director Grant or award · Phantom Stock +361.66 $82.95 $30K 98,268.05
2020-09-30 Coe Mary Ellen Director Grant or award · Phantom Stock +391.8 $82.95 $33K 7,406.43
2020-08-13 Chattopadhyay Sanat Exe V-P & Pres. MMD Sale −10,380 $83.01 $862K 67,373.36
2020-08-05 Clyburn Frank EVP, Chief Commercial Officer Exercise or conversion +18,876 99,639.11
2020-08-05 Clyburn Frank EVP, Chief Commercial Officer Sale −18,876 $81.55 $1.5M 80,763.11
2020-08-05 Clyburn Frank EVP, Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) −18,876 0
2020-07-17 Gerberding Julie L. EVP Strat Comm, GI Pub Policy Exercise or conversion +18,111 62,862.14
2020-07-17 Gerberding Julie L. EVP Strat Comm, GI Pub Policy Sale −18,111 $80.00 $1.4M 44,751.14
2020-07-17 Gerberding Julie L. EVP Strat Comm, GI Pub Policy Sale −18,174 $80.01 $1.5M 26,577.14
2020-07-17 Gerberding Julie L. EVP Strat Comm, GI Pub Policy Exercise or conversion · Stock Option (Right to Buy) −18,111 0
2020-06-30 WENDELL PETER C Director Grant or award · Phantom Stock +387.95 $77.33 $30K 97,156.53
2020-06-30 Seidman Christine E Director Grant or award · Phantom Stock +210.14 $77.33 $16K 2,837.98
2020-06-30 Coe Mary Ellen Director Grant or award · Phantom Stock +420.28 $77.33 $32K 6,963.92
2020-05-29 Thulin Inge G Director Grant or award · Phantom Stock +2,477.7 $80.72 $200K 10,326.03
2020-05-29 Warden Kathy J Director Grant or award · Phantom Stock +2,477.7 $80.72 $200K 2,591.5
2020-05-29 WENDELL PETER C Director Grant or award · Phantom Stock +2,477.7 $80.72 $200K 96,768.58

Page 48 of 52 · 1,021 trades